Cite
HARVARD Citation
Dai, S. et al. (2022). Addition of roxadustat to erythropoiesis‐stimulating agent (ESA) effectively corrects ESA‐hyporesponsive anaemia in patients on peritoneal dialysis. Journal of clinical pharmacy and therapeutics. pp. 1525-1530. [Online].